Neusignal Therapeutics
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $12M
Investors
- 7
About Neusignal Therapeutics
Based in Tokyo, Japan, and founded in 2022, Neusignal Therapeutics Inc. engages in the research and development of drugs to treat dementia and mental disorders. The company is dedicated to advancing the treatment of central nervous system diseases, particularly Alzheimer's disease (AD), through the development of small-molecule drugs. Neusignal Therapeutics also addresses the challenges posed by an aging population and the burden of nursing care, and protects brain health, through small-molecule oral drugs that enable fundamental treatment at home. The firm benefits from a strong collaboration system with Tohoku University and extensive networks with pharmaceutical companies and key opinion leaders in the AD field.
Who invested in Neusignal Therapeutics
7 investors across 2 rounds
See all investors in Neusignal Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neusignal Therapeutics
Who invested in Neusignal Therapeutics?
Neusignal Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neusignal Therapeutics raised?
Neusignal Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Neusignal Therapeutics last raise money?
Neusignal Therapeutics's most recent round on record is a Series A, in Jan 2025.
What does Neusignal Therapeutics do?
Based in Tokyo, Japan, and founded in 2022, Neusignal Therapeutics Inc.
Where is Neusignal Therapeutics headquartered?
Neusignal Therapeutics is headquartered in Tokyo, Japan.
Which VCs invest in companies like Neusignal Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Neusignal Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Neusignal Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.